To confirm whether TAMs express IL-10 and cathepsin B in protein level, 6 NSCLC (3 late stage (IIIA) and 3 early stage (Ia- Ib)) were randomly selected to perform IHC using antibody against CD68, IL-10 and cathepsin B on serial sections. Here, CD68 is linked to non-small cell lung carcinoma.